Fund I Portfolio
Fund II Portfolio
MEDICAL DEVICES
INDUSTRIAL CHEMISTRY
Fund II - Investment 3
E-Leviate
A medtech platform creating advanced non-surgical solutions for women’s health.
Their first product, E-Leviate, is a novel drug-device combination that provides structural and therapeutic support as a single integrated solution for a range of common gynaecological conditions that affect 50%+ of women during their lifetime.
Broad patents have been secured in the US, India and Australia demonstrating strong execution to-date.
Pre-Seed round of $500k, led by Outset Ventures, to complete initial clinical trials.
As I take the next step with E-Leviate, I value being able to sit alongside other Deep Tech Entrepreneurs and the experienced team at Outset. Mike and Angus have helped me move much faster with the capital raise and I will always be grateful for the late-night pitch practices!
Fund II - Investment 1
Ternary Kinetics
Heavy transport represents 12% of global transport energy. Ternary is transforming electrification of the heavy transport sector through a sustainable liquid energy source that can be stored, pumped, and shipped.
Founded at Outset Ventures by three second time founders with direct involvement from two IC members. We led the Pre-Seed round of $3m in an off-market deal, demonstrating our unique deal-flow access.
Minimum Viable Product for on vehicle demonstration with commercial partners currently under development.
Outset goes beyond being a day zero investor; they’re involved from day minus 100. From the earliest conception to leading our first round, they’ve accelerated our progress and helped us build a world-class board and team, unmatched anywhere else in the world.
Fund II - Investment 2
OpenStar
OpenStar are building a fusion reactor to generate safe, clean, carbon-free, base load electricity in a way that is economically scalable. They leverage a reactor geometry with known stable plasma physics… it’s not a Tokamak.
Pre-Seed and a $10m Seed round were both led by Outset Ventures Fund I with co-investment from Icehouse Ventures and Blackbird. Outset Ventures Fund II has invested alongside Fund I in a pre-Series A round at an attractive entry price.
Founder and core team originate from Robinson Research Institute; home of the world leading HTS research team.
When you start out to build a fusion reactor you need wildly ambitious people who can champion your vision. Angus and the Outset team tripled our initial ambitions, and round size, and followed through by helping us build a world class syndicate in a tough capital market. There’s no better lead for ambitious founders in NZ.